C-reactive protein as a marker of ventilator-associated penumonia resolution: A pilot study

European Respiratory Journal

Volumn 25, Issue 5, 2005, Pages 804-812

  Povoa P ^a   Coelho, L ^a   Almeida, E ^a   Fernandes, A ^a   Mealha, R ^a   Moreira, P ^a   Sabino, H ^a  

^a HOSPITAL GARCIA DE ORTA   (Portugal)

Author keywords

C reactive protein; Intensive care unit; Outcome; Temperature; Ventilator associated pneumonia; White cell count

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; BODY TEMPERATURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DRUG RESPONSE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; LEUKOCYTE COUNT; MALE; MORTALITY; OUTCOMES RESEARCH; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; BODY TEMPERATURE; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PILOT PROJECTS; PNEUMONIA; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 18744367590     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00071704     Document Type: Article

References (35)

1. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-644.
2. Cook D. Ventilator associated pneumonia: perspectives on the burden of illness. Intensive Care Med 2000; 26: Suppl. 1, S31-S37.
3. Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 275: 866-869.
4. Ewig S, Bauer T, Torres A. The pulmonary physician in critical care · 4: nosocomial pneumonia. Thorax 2002; 57: 366-371.
5. Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001; 163: 1371-1375.
6. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996; 153: 1711-1725.
7. Montravers P, Fagon JY, Chastre J, et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 1993; 147: 38-44.
8. Luna CM, Blanzaco D, Niederman MS, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003; 31: 676-682.
9. Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998; 279: 1452-1457.
10. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91: 1351-1357.
11. Povoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005; 11: 101-108.
12. Povoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med 2002; 28: 235-243.
13. Cox ML, Rudd AG, Gallimore R, Hodkinson HM, Pepys MB. Real-time measurement of serum C-reactive protein in the management of infection in the elderly. Age Ageing 1986; 15: 257-266.
14. Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995; 21: 602-605.
15. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462-474.
16. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-155.
17. Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26: 1793-1800.
18. Meduri GU, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 1992; 102: 557S-564S.
19. Chastre J, Fagon JY, Bornet-Lecso M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 152: 231-240.
20. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
21. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240: 1285-1293.
22. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843.
23. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
24. Ferrer M, Ioanas M, Torres A. Evaluation of non-responding patients with ventilator-associated pneumonia. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin, Springer, 2002; pp. 365-375.
25. Garrard CS, A'Court CD. The diagnosis of pneumonia in the critically ill. Chest 1995; 108: 17S-25S.
26. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and non-bronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143: 1121-1129.
27. Fabregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54: 867-873.
28. Fartoukh M, Maitre B, Honore S, Cerf C, Zahar JR, Brun-Buisson C. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med 2003; 168: 173-179.
29. Hogarth MB, Gallimore R, Savage P, et al. Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient. Age Ageing 1997; 26: 153-158.
30. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498-504.
31. Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123: 2043-2049.
32. Reny JL, Vuagnat A, Ract C, Benoit MO, Safar M, Fagon JY. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002; 30: 529-535.
33. Abramson N, Melton B. Leukocytosis: basics of clinical assessment. Am Fam Physician 2000; 62: 2053-2060.
34. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812.
35. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141-212.